EUVIMEDEUVIMED entdecken
Crossref

Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca 2+ Homeostasis and Hepatic Insulin Signaling

Bayaraa Amgalan, Seung Wan Noh, Han Sol Ryu, Yeon-Ju Kim, Hyun-Jung Ahn, Ok-Hee Kim, Byung-Chul Oh

Diabetes & Metabolism Journal · 04.11.2026

DOI: 10.4093/dmj.2026.0022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, online erschienen am 04.11.2026. Verfasst von Bayaraa Amgalan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Science and Technology, Gachon Advanced Institute for Health Science and Technology, Gachon University, Incheon, Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CalciumDapagliflozinFatty liverGene expression profilingInsulin resistanceSarcoplasmic reticulum calciumtransporting ATPasesSodium-glucose transporter 2 inhibitors

Autor:innen und Institutionen

  • Department of Health Science and Technology, Gachon Advanced Institute for Health Science and Technology, Gachon University, Incheon, Korea.
  • Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon, Korea.
  • Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon, Korea. ohkim323@gmail.com.
  • Department of Health Science and Technology, Gachon Advanced Institute for Health Science and Technology, Gachon University, Incheon, Korea. bcoh@gachon.ac.kr.
  • Department of Physiology, Lee Gil Ya Cancer and Diabetes Institute, Gachon University College of Medicine, Incheon, Korea. bcoh@gachon.ac.kr.

Zitieren

APA

Amgalan, B., Noh, S. W., Ryu, H. S., Kim, Y. J., Ahn, H. J., Kim, O. H., & Oh, B. C. (2026). Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca 2+ Homeostasis and Hepatic Insulin Signaling. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2026.0022

Vancouver

Amgalan B, Noh SW, Ryu HS, Kim YJ, Ahn HJ, Kim OH, et al. Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca 2+ Homeostasis and Hepatic Insulin Signaling. Diabetes & Metabolism Journal. 2026. doi:10.4093/dmj.2026.0022

BibTeX
@article{Amgalan2026,
  author = {Amgalan, Bayaraa and Noh, Seung Wan and Ryu, Han Sol and Kim, Yeon-Ju and Ahn, Hyun-Jung and Kim, Ok-Hee and Oh, Byung-Chul},
  title = {Dapagliflozin Ameliorates Steatohepatitis by Restoring Ca 2+ Homeostasis and Hepatic Insulin Signaling},
  journal = {Diabetes & Metabolism Journal},
  year = {2026},
  doi = {10.4093/dmj.2026.0022}
}
Kostenlos starten →